← FDA DRUG APPROVALS

FDA ANDA · ANDA072999

DOPAMINE HYDROCHLORIDE

Sponsor: TEVA PARENTERAL

APPLICATION
ANDA072999
TYPE
ANDA
ORIGINAL APPROVAL
1991-10-23
LATEST ACTION
2001-06-21
ROUTE
INJECTION
DOSAGE FORM
INJECTABLE
MARKETING STATUS
Discontinued

Products

DOPAMINE HYDROCHLORIDEDiscontinued
DOPAMINE HYDROCHLORIDE 40MG/ML · INJECTABLE · INJECTION

Approval history

2001-06-21Labeling · Supplement 3AP
1998-04-23Labeling · Supplement 2AP
1997-09-09Labeling · Supplement 1AP
1991-10-23OriginalAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →